The NK1 antagonist GR203040 inhibits cyclophosphamide-induced damage in the rat and ferret bladder

General Pharmacology

Volumn 29, Issue 2, 1997, Pages 245-250

  Alfieri, Anna ^a,b   Gardner, Christopher ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Bladder; Cyclophosphamide; Ferret; Neurogenic inflammation; NK1 receptor antagonist; Plasma protein extravasation; Rat

Indexed keywords

[2 METHOXY 5 (1 TETRAZOLYL)BENZYL](2 PHENYL 3 PIPERIDINYL)AMINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; GRANISETRON; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; PLASMA PROTEIN; SEROTONIN 3 ANTAGONIST; PIPERIDINE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER INJURY; CONTROLLED STUDY; DUODENUM; EXTRAVASATION; FERRET; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; JEJUNUM; KIDNEY; LUNG; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING; ANIMAL; BLADDER; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; WISTAR RAT;

ANIMALS; BLOOD PROTEINS; CYCLOPHOSPHAMIDE; FERRETS; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-1; TETRAZOLES; URINARY BLADDER;

EID: 0030610541     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00482-X     Document Type: Article

References (13)

1. Ahluwalia A., Maggi C. A., Santiccioli P., Lecci A. and Giuliani, S. (1994) Characterisation of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmac. 111, 1017-1022.
2. Barnes P. J., Belvisi M. G. and Rogers D. F. (1990) Modulation of neurogenic inflammation: novel approaches to inflammatory disease. TIPS 11, 185-189.
3. Beattie D. T., Connor H. E., Hawcock A. B., Perren M. J. and Ward P. (1995) Pharmacology of GR203040, a potent and selective non-peptide tachykinin NK1 receptor antagonist. Br. J. Pharmac. 116, 3149-3157.
4. 3 receptor antagonist BRL 43694. Br. J. Cancer 58, 644-650.
5. 1 receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmac. 249, R3-R4.
6. Chahl L. A. (1988) Antidromic vasodilatation and neurogenic inflammation. Pharmac. Ther. 37, 275-300.
7. Cox P. J. (1979) Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem. Pharmac. 28, 2045-2049.
8. Fraiser L. H., Sarathchandra K. and Kehrer J. P. (1991) Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs 42, 781-795.
9. 1 receptor antagonist GR203040. Br. J. Pharmac. 116, 3158-3163.
10. 2α for the prophylaxis of cyclophosphamide-induced cystitis in the rat. J. Urol. 144, 1500-1504.
11. Maggi C. A., Santicioli P., Abelli L., Parlani M., Capasso M., Conte B., Gutliani S. and Meli A. (1987) Regional differences in the effects of capsaicin and tachykinins on motor activity and vascular permeability of the rat lower urinary tract. Naunyn-Schmiedeberg's Arch. Pharmac. 335, 636-645.
12. Saria A. and Lundberg J. M. (1983) Evans blue fluorescence: quantitative and morphological evaluation of vascular permeability in animal tissues. J. Neurosci. Methods 8, 41-49.
13. 3-receptor antagonist, GR38032F. Cancer Treat. Rev. 14, 333-336.